Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ENGN
#2915
enGene Therapeutics Inc. Common Stock
7.600
0
USD
+2.29%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.29%
Changement Mensuel
+4.40%
Evolution sur 6 mois
-9.52%
Changement Annuel
-9.52%
Clôture Précédente
7.430
0
Open
7.600
0
Bid
Ask
Low
7.600
0
High
7.600
0
Volume
8
Marchés
Actions des Marchés US
Soins de Santé
ENGN
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.2 M
50.98 M
66.98 M
—
Valuation ratios
Enterprise value
392.22 M
303.16 M
464.6 M
1.5 B
Price to earnings ratio
0.13
6.06
3.15
12.2
Price to sales ratio
-3.87
-875.32
-122.86 K
-208.66 K
Price to cash flow ratio
-0.56
-6.93
-3.71
-13.52
Price to book ratio
0.19
1.23
2.2
3.2
Enterprise value to EBITDA ratio
-12.99
-4.46
-3.53
-11.85
Profitability ratios
Return on assets %
-1.15
-0.18
-0.53
-0.47
Return on equity %
-1.38
-0.2
-0.7
-0.59
Return on invested capital %
-3 671.05
-660.95
-879.54
-1 028.89
Gross margin %
100
100
100
400
Operating margin %
727.93
16.31 K
4.11 M
249.9 K
EBITDA margin %
822.35
16.33 K
4.09 M
249.72 K
Net margin %
2 790.98
14.44 K
3.91 M
243.62 K
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
16.25
16.87
6.3
41.05
Inventory turnover
—
—
—
—
Asset turnover
-0.04
-0
-0
-0
Solvency ratios
Debt to assets ratio
0.11
0.08
0.14
0.47
Debt to equity ratio
0.13
0.09
0.19
0.58
Long term debt to total assets ratio
0.11
0.07
0.11
0.36
Long term debt to total equity ratio
0.13
0.08
0.14
0.45
Per share metrics
Operating cash flow per share
-35.72
-1.28
-1.94
-1.87
EBIT per share
-42.79
-1.66
-2.41
-2.36
EBITDA per share
-42.51
-1.65
-2.4
-2.35
Total debt per share
14.12
0.66
0.62
2.23
Cash per share
117.7
6.31
3.79
16.1
Net current asset value per share
123.36
6.55
3.94
16.84
Tangible book value per share
104.66
7.22
3.28
15.85
Working capital per share
115.77
6.16
3.31
15.1
Book value per share
104.66
7.22
3.28
15.85
Nouvelles
UBS abaisse l’objectif de cours d’Engene Holdings en raison des coûts d’essais
enGene Holdings: Key Catalysts Incoming For 2026 (NASDAQ:ENGN)
Citizens réitère sa recommandation sur Engene Holdings avec le calendrier BLA
Citizens reiterates Engene Holdings stock rating on BLA timeline
Guggenheim abaisse l’objectif de cours d’Engene à 27$
Engene stock price target lowered to $27 by Guggenheim on estimates
Raymond James réitère sa recommandation d’achat fort sur Engene Holdings
Raymond James reiterates Engene Holdings stock Strong Buy rating
Les meilleures actions biotechnologiques SMID Cap à surveiller selon Morgan Stanley
Top SMID Cap Biotech Stocks to Watch According to Morgan Stanley
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Jefferies initie la couverture de l’action Engene avec une recommandation d’achat